Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 3
2004 1
2005 1
2006 3
2007 1
2008 1
2009 2
2010 5
2011 2
2012 5
2013 11
2014 7
2015 7
2016 5
2017 10
2018 8
2019 12
2020 33
2021 53
2022 33
2023 21
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

208 results

Results by year

Filters applied: . Clear all
Page 1
Adjunctive immunotherapeutic agents in patients with sepsis and septic shock: a multidisciplinary consensus of 23.
Girardis M, Coloretti I, Antonelli M, Berlot G, Busani S, Cortegiani A, De Pascale G, De Rosa FG, De Rosa S, Donadello K, Donati A, Forfori F, Giannella M, Grasselli G, Montrucchio G, Oliva A, Pasero D, Piazza O, Romagnoli S, Tascini C, Viaggi B, Tumbarello M, Viale P. Girardis M, et al. J Anesth Analg Crit Care. 2024 Apr 30;4(1):28. doi: 10.1186/s44158-024-00165-3. J Anesth Analg Crit Care. 2024. PMID: 38689337 Free PMC article.
Advances and Challenges in Sepsis Management: Modern Tools and Future Directions.
Santacroce E, D'Angerio M, Ciobanu AL, Masini L, Lo Tartaro D, Coloretti I, Busani S, Rubio I, Meschiari M, Franceschini E, Mussini C, Girardis M, Gibellini L, Cossarizza A, De Biasi S. Santacroce E, et al. Among authors: girardis m. Cells. 2024 Mar 2;13(5):439. doi: 10.3390/cells13050439. Cells. 2024. PMID: 38474403 Free PMC article. Review.
Intravenous fosfomycin in combination regimens as a treatment option for difficult-to-treat infections due to multi-drug-resistant Gram-negative organisms: A real-life experience.
Meschiari M, Faltoni M, Kaleci S, Tassoni G, Orlando G, Franceschini E, Burastero G, Bedini A, Serio L, Biagioni E, Melegari G, Venturelli C, Sarti M, Bertellini E, Girardis M, Mussini C. Meschiari M, et al. Among authors: girardis m. Int J Antimicrob Agents. 2024 May;63(5):107134. doi: 10.1016/j.ijantimicag.2024.107134. Epub 2024 Mar 5. Int J Antimicrob Agents. 2024. PMID: 38453094
A genome-wide association study for survival from a multi-centre European study identified variants associated with COVID-19 risk of death.
Minnai F, Biscarini F, Esposito M, Dragani TA, Bujanda L, Rahmouni S, Alarcón-Riquelme ME, Bernardo D, Carnero-Montoro E, Buti M, Zeberg H, Asselta R, Romero-Gómez M; GEN-COVID Multicenter Study; Fernandez-Cadenas I, Fallerini C, Zguro K, Croci S, Baldassarri M, Bruttini M, Furini S, Renieri A, Colombo F. Minnai F, et al. Sci Rep. 2024 Feb 6;14(1):3000. doi: 10.1038/s41598-024-53310-x. Sci Rep. 2024. PMID: 38321133 Free PMC article.
Epidemiology and risk factors for mortality in critically ill patients with pancreatic infection.
Dejonckheere M, Antonelli M, Arvaniti K, Blot K, CreaghBrown B, de Lange DW, De Waele J, Deschepper M, Dikmen Y, Dimopoulos G, Eckmann C, Francois G, Girardis M, Koulenti D, Labeau S, Lipman J, Lipovestky F, Maseda E, Montravers P, Mikstacki A, Paiva J, Pereyra C, Rello J, Timsit J, Vogelaers D, Blot S; Abdominal Sepsis Study (AbSeS) group on behalf of the Trials Group of the European Society of Intensive Care Medicine. Dejonckheere M, et al. Among authors: girardis m. J Intensive Med. 2023 Aug 30;4(1):81-93. doi: 10.1016/j.jointm.2023.06.004. eCollection 2024 Jan. J Intensive Med. 2023. PMID: 38263964 Free PMC article.
Editorial: Outcome of sepsis and prediction of mortality risk.
Munari E, Minicucci MF, Ming Z, Girardis M, Busani S. Munari E, et al. Among authors: girardis m. Front Med (Lausanne). 2023 Dec 19;10:1338938. doi: 10.3389/fmed.2023.1338938. eCollection 2023. Front Med (Lausanne). 2023. PMID: 38169760 Free PMC article. No abstract available.
Profiling the dysregulated immune response in sepsis: overcoming challenges to achieve the goal of precision medicine.
Cajander S, Kox M, Scicluna BP, Weigand MA, Mora RA, Flohé SB, Martin-Loeches I, Lachmann G, Girardis M, Garcia-Salido A, Brunkhorst FM, Bauer M, Torres A, Cossarizza A, Monneret G, Cavaillon JM, Shankar-Hari M, Giamarellos-Bourboulis EJ, Winkler MS, Skirecki T, Osuchowski M, Rubio I, Bermejo-Martin JF, Schefold JC, Venet F. Cajander S, et al. Among authors: girardis m. Lancet Respir Med. 2024 Apr;12(4):305-322. doi: 10.1016/S2213-2600(23)00330-2. Epub 2023 Dec 21. Lancet Respir Med. 2024. PMID: 38142698 Review.
High versus standard blood pressure target in hypertensive high-risk patients undergoing elective major abdominal surgery: a study protocol for the HISTAP randomized clinical trial.
Messina A, Cortegiani A, Romagnoli S, Sotgiu G, Piccioni F, Donadello K, Girardis M, Noto A, Maggiore SM, Antonelli M, Cecconi M. Messina A, et al. Among authors: girardis m. J Anesth Analg Crit Care. 2023 Dec 1;3(1):50. doi: 10.1186/s44158-023-00133-3. J Anesth Analg Crit Care. 2023. PMID: 38041208 Free PMC article.
Association between Pulmonary Aspergillosis and Cytomegalovirus Reactivation in Critically Ill COVID-19 Patients: A Prospective Observational Cohort Study.
Caciagli V, Coloretti I, Talamonti M, Farinelli C, Gatto I, Biagioni E, Sarti M, Franceschini E, Meschiari M, Mussini C, Tonelli R, Clini E, Girardis M, Busani S, Modena Covid-Working Group. Caciagli V, et al. Among authors: girardis m. Viruses. 2023 Nov 15;15(11):2260. doi: 10.3390/v15112260. Viruses. 2023. PMID: 38005936 Free PMC article.
208 results